Paracrinal Hedgehog Signaling Activates Pancreatic Stellate Cell by Regulating Metabolism in Pancreatic Cancer

Qinhong Xu,Wanxing Duan,Jianjun Lei,Rong Li,Liang Sheng,Xin Chen,Liang Han,Qingyong Ma

DOI: https://doi.org/10.1093/annonc/mdt203.50

IF: 51.769

2013-01-01

Annals of Oncology

Abstract:Background: It is now widely recognized that the pancreatic stellate cells (PSC) promote the proliferation and metastasis of pancreatic cancer cell via changes in cytokine secretion and extracellular matrix remodeling. The abundant tumor-associated promoters involve deregulated accumulation of activated PSCs derived from the quiescent PSCs, but the mechanisms that control transdifferentiation of PSCs are poorly understood. We investigated whether the paracrinal Hedgehog (Hh) signaling activates pancreatic stellate cell by regulating metabolism. Methods: PSC were isolated from rat pancreas. Oil red O staining indicated lipid droplets in PSCs. qRT-PCR and Western-blot were used to detect the activated PSCs markers, the changes of metabolic genes and matrix metalloproteinases (MMPs) when Hh signaling were activated in PSCs. To determine whether metabolism influenced transdifferentiation, we used 2-deoxy-glucose (2DG) and FX11 to disrupt glycolysis and lactate production in PSCs. To determine if the Hh signaling pathway affects glycolytic activity of the PSCs, we used specific small interfering RNA (SMO-siRNA) to inhibit the gene expression of SMO. Results: Additional Hh and PSCs co-cultured with AsPc-1 (a human PADC line expressing high Shh protein) could induce transdifferentiation of cultured, quiescent into activated PSCs. We found that the lactate accumulate in culture medium by ELISA, the expressions of MMPs and genes that regulate glycolysis required increased by PCR and Western-blot, and the lipid droplets disappeared in PSCs by oil red O staining. The Inhibitors of Hh signaling, glycolysis, or lactate accumulation converted activated to quiescent PSCs. Conclusion: Paracrinal Hedgehog signaling in pancreatic cancer activates pancreatic stellate cell by regulating metabolism. The activated PSCs could promote the progression of pancreatic cancer. These findings might provide a new orientation for the therapy of pancreatic cancer.